Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 7/2009

01.07.2009 | Editorial

Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging

verfasst von: Habib Zaidi

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 7/2009

Einloggen, um Zugang zu erhalten

Excerpt

This is an exciting time for molecular imaging as we are witnessing a convergence and combination of various imaging modalities driven by an unprecedented multidisciplinary collaboration between scientists. A consequence of this growth is a paradigm shift in health care delivery that is now revolutionizing clinical practice. Within the spectrum of macroscopic medical imaging, sensitivity ranges from the detection of millimolar to submillimolar concentrations of contrast media with computed tomography (CT) and magnetic resonance imaging (MRI), respectively, to picomolar concentrations in positron emission tomography (PET): a 108–109 difference [1]. Despite the remarkable progress and outstanding scientific innovations achieved and the much worthwhile successful research carried out both in academic and corporate settings, there are still plenty of open research questions that offer ample opportunities for the new generation of molecular imaging scientists [2]. There is no shortage of challenges and opportunities nowadays for developing novel molecular imaging probes and technologies and for establishing their role through innovative applications in clinical and research settings. The only limit is the imagination and creativity of the investigators and the challenge is the ability of opinion leaders to attract the best scientists into this discipline. …
Literatur
1.
Zurück zum Zitat Jones T. Molecular imaging with PET—the future challenges. Br J Radiol 2002;75:S6–15.PubMed Jones T. Molecular imaging with PET—the future challenges. Br J Radiol 2002;75:S6–15.PubMed
4.
Zurück zum Zitat Fullerton GD, Hazle JD. The development of technologies for molecular imaging should be driven principally by biological questions to be addressed rather than by simply modifying existing imaging technologies. Med Phys 2005;32:1231–3. doi:10.1118/1.1866141.PubMedCrossRef Fullerton GD, Hazle JD. The development of technologies for molecular imaging should be driven principally by biological questions to be addressed rather than by simply modifying existing imaging technologies. Med Phys 2005;32:1231–3. doi:10.​1118/​1.​1866141.PubMedCrossRef
11.
Zurück zum Zitat Beyer T, Pichler B. A decade of combined imaging: from a PET attached to a CT to a PET inside an MR. Eur J Nucl Med Mol Imaging 2009; In press. Beyer T, Pichler B. A decade of combined imaging: from a PET attached to a CT to a PET inside an MR. Eur J Nucl Med Mol Imaging 2009; In press.
13.
Zurück zum Zitat Gaa J, Rummeny EJ, Seemann MD. Whole-body imaging with PET/MRI. Eur J Med Res 2004;9:309–12.PubMed Gaa J, Rummeny EJ, Seemann MD. Whole-body imaging with PET/MRI. Eur J Med Res 2004;9:309–12.PubMed
14.
Zurück zum Zitat Seemann MD. Whole-body PET/MRI: the future in oncological imaging. Technol Cancer Res Treat 2005;4:577–82.PubMed Seemann MD. Whole-body PET/MRI: the future in oncological imaging. Technol Cancer Res Treat 2005;4:577–82.PubMed
15.
Zurück zum Zitat Ruf J, Lopez Hanninen E, Bohmig M, Koch I, Denecke T, Plotkin M, et al. Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer. Pancreatology 2006;6:512–9. doi:10.1159/000096993.PubMedCrossRef Ruf J, Lopez Hanninen E, Bohmig M, Koch I, Denecke T, Plotkin M, et al. Impact of FDG-PET/MRI image fusion on the detection of pancreatic cancer. Pancreatology 2006;6:512–9. doi:10.​1159/​000096993.PubMedCrossRef
16.
Zurück zum Zitat Schlemmer HP, Pichler BJ, Krieg R, Heiss WD. An integrated MR/PET system: prospective applications. Abdom Imaging 2009; In press. Schlemmer HP, Pichler BJ, Krieg R, Heiss WD. An integrated MR/PET system: prospective applications. Abdom Imaging 2009; In press.
18.
Zurück zum Zitat Del Guerra A, Bartoli A, Belcari N, Herbert D, Motta A, Vaiano A, et al. Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging. IEEE Trans Nucl Sci 2006;53:1078–83. doi:10.1109/TNS.2006.871900.CrossRef Del Guerra A, Bartoli A, Belcari N, Herbert D, Motta A, Vaiano A, et al. Performance evaluation of the fully engineered YAP-(S)PET scanner for small animal imaging. IEEE Trans Nucl Sci 2006;53:1078–83. doi:10.​1109/​TNS.​2006.​871900.CrossRef
19.
20.
Zurück zum Zitat Gulsen G, Birgul O, Unlu MB, Shafiiha R, Nalcioglu O. Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat 2006;5:351–63.PubMed Gulsen G, Birgul O, Unlu MB, Shafiiha R, Nalcioglu O. Combined diffuse optical tomography (DOT) and MRI system for cancer imaging in small animals. Technol Cancer Res Treat 2006;5:351–63.PubMed
22.
Zurück zum Zitat Parnham KB, Chowdhury S, Li J, Wagenaar DJ, Patt BE. Second-generation, tri-modality pre-clinical imaging system. IEEE Nuclear Science Symposium Conference Record 2006;3:1802–5. Parnham KB, Chowdhury S, Li J, Wagenaar DJ, Patt BE. Second-generation, tri-modality pre-clinical imaging system. IEEE Nuclear Science Symposium Conference Record 2006;3:1802–5.
23.
Zurück zum Zitat Peter J, Semmler W. A modular design triple-modality SPECT-CT-ODT small animal imager. Eur J Nucl Med Mol Imaging 2007;34:S158. abstract. Peter J, Semmler W. A modular design triple-modality SPECT-CT-ODT small animal imager. Eur J Nucl Med Mol Imaging 2007;34:S158. abstract.
24.
Zurück zum Zitat Bidaut LM, Pascual-Marqui R, Delavelle J, Naimi A, Seeck M, Michel C, et al. Three- to five-dimensional biomedical multisensor imaging for the assessment of neurological (dys) function. J Digit Imaging 1996;9:185–98.PubMedCrossRef Bidaut LM, Pascual-Marqui R, Delavelle J, Naimi A, Seeck M, Michel C, et al. Three- to five-dimensional biomedical multisensor imaging for the assessment of neurological (dys) function. J Digit Imaging 1996;9:185–98.PubMedCrossRef
25.
26.
Zurück zum Zitat Kummer C, Winkeler A, Dittmar C, Bauer B, Rueger MA, Rueckriem B, et al. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector. Mol Imaging 2007;6:181–92.PubMed Kummer C, Winkeler A, Dittmar C, Bauer B, Rueger MA, Rueckriem B, et al. Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector. Mol Imaging 2007;6:181–92.PubMed
27.
Zurück zum Zitat Tian J, Yang X, Yu L, Chen P, Xin J, Ma L, et al. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG. J Nucl Med 2008;49:186–94. doi:10.2967/jnumed.107.044966.PubMedCrossRef Tian J, Yang X, Yu L, Chen P, Xin J, Ma L, et al. A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG. J Nucl Med 2008;49:186–94. doi:10.​2967/​jnumed.​107.​044966.PubMedCrossRef
28.
Zurück zum Zitat Nakamura M, Takeda K, Ichihara T, Motomura N, Shimizu H, Saito Y, et al. Feasibility of simultaneous stress 99mTc-sestamibi/rest 201Tl dual-isotope myocardial perfusion SPECT in the detection of coronary artery disease. J Nucl Med 1999;40:895–903.PubMed Nakamura M, Takeda K, Ichihara T, Motomura N, Shimizu H, Saito Y, et al. Feasibility of simultaneous stress 99mTc-sestamibi/rest 201Tl dual-isotope myocardial perfusion SPECT in the detection of coronary artery disease. J Nucl Med 1999;40:895–903.PubMed
29.
Zurück zum Zitat El Fakhri G, Moore SC, Maksud P, Aurengo A, Kijewski MF. Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT. J Nucl Med 2001;42:300–8.PubMed El Fakhri G, Moore SC, Maksud P, Aurengo A, Kijewski MF. Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT. J Nucl Med 2001;42:300–8.PubMed
36.
Zurück zum Zitat Black NF, Kadrmas DJ. Measurement of secondary tracers in FDG tumor imaging by rapid multi-tracer PET. Proceedings IEEE Nuclear Science Symposium and Medical Imaging Conference; 2007; Honolulu, Hawaii; vol. 4. p. 2825–32. Black NF, Kadrmas DJ. Measurement of secondary tracers in FDG tumor imaging by rapid multi-tracer PET. Proceedings IEEE Nuclear Science Symposium and Medical Imaging Conference; 2007; Honolulu, Hawaii; vol. 4. p. 2825–32.
38.
Zurück zum Zitat Verhaeghe J, D’Asseler Y, De Winter O, Staelens S, Lemahieu I. Simultaneous dual tracer NH3/FDG cardiac PET imaging: a simulation study. J Nucl Med 2005;46:56P. abstract. Verhaeghe J, D’Asseler Y, De Winter O, Staelens S, Lemahieu I. Simultaneous dual tracer NH3/FDG cardiac PET imaging: a simulation study. J Nucl Med 2005;46:56P. abstract.
39.
Zurück zum Zitat El Fakhri G, Sitek A, Guérin B. Simultaneous dual tracer PET using generalized factor analysis of dynamic sequences. Proceedings IEEE Nuclear Science Symposium and Medical Imaging Conference; 2006; San Diego, CA. p. 2128–30. El Fakhri G, Sitek A, Guérin B. Simultaneous dual tracer PET using generalized factor analysis of dynamic sequences. Proceedings IEEE Nuclear Science Symposium and Medical Imaging Conference; 2006; San Diego, CA. p. 2128–30.
Metadaten
Titel
Navigating beyond the 6th dimension: a challenge in the era of multi-parametric molecular imaging
verfasst von
Habib Zaidi
Publikationsdatum
01.07.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 7/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-009-1095-z

Weitere Artikel der Ausgabe 7/2009

European Journal of Nuclear Medicine and Molecular Imaging 7/2009 Zur Ausgabe